Found 82 Enz. Inhib. hit(s) with all data for entry = 9103 TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 11nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 14nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 15nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 16nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 21nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 22nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 24nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 24nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 27nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 27nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 30nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 31nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 32nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 34nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 35nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 35nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 37nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 38nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 38nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 40nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 40nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 44nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 47nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 47nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 56nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 59nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 70nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 75nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 80nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 82nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 89nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 98nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 100nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 110nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 110nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 110nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 120nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 140nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 160nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
US Patent
Affinity DataIC50: 160nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
